Literature DB >> 33500318

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Anna Morra1, Audrey Y Jung2, Marjanka K Schmidt3,4, Jenny Chang-Claude2,5, Sabine Behrens2, Renske Keeman1, Thomas U Ahearn6, Hoda Anton-Culver7, Volker Arndt8, Annelie Augustinsson9, Päivi K Auvinen10,11,12, Laura E Beane Freeman6, Heiko Becher13,14, Matthias W Beckmann15, Carl Blomqvist16,17, Stig E Bojesen18,19,20, Manjeet K Bolla21, Hermann Brenner8,22,23, Ignacio Briceno24, Sara Y Brucker25, Nicola J Camp26, Daniele Campa2,27, Federico Canzian28, Jose E Castelao29, Stephen J Chanock6, Ji-Yeob Choi30,31, Christine L Clarke, Fergus J Couch32, Angela Cox33, Simon S Cross34, Kamila Czene35, Thilo Dörk36, Alison M Dunning37, Miriam Dwek38, Douglas F Easton21,37, Diana M Eccles39, Kathleen M Egan40, D Gareth Evans41,42, Peter A Fasching15,43, Henrik Flyger44, Manuela Gago-Dominguez45,46, Susan M Gapstur47, José A García-Sáenz48, Mia M Gaudet47, Graham G Giles49,50,51, Mervi Grip52, Pascal Guénel53, Christopher A Haiman54, Niclas Håkansson55, Per Hall35,56, Ute Hamann57, Sileny N Han58, Steven N Hart59, Mikael Hartman60,61, Jane S Heyworth62, Reiner Hoppe63,64, John L Hopper50, David J Hunter65,66, Hidemi Ito67,68, Agnes Jager69, Milena Jakimovska70, Anna Jakubowska71,72, Wolfgang Janni73, Rudolf Kaaks2, Daehee Kang30,31,74, Pooja Middha Kapoor2,75, Cari M Kitahara76, Stella Koutros6, Peter Kraft66,77, Vessela N Kristensen, James V Lacey78,79, Diether Lambrechts80,81, Loic Le Marchand82, Jingmei Li83, Annika Lindblom84,85, Jan Lubiński71, Michael Lush21, Arto Mannermaa10,86,87, Mehdi Manoochehri57, Sara Margolin56,88, Shivaani Mariapun89,90, Keitaro Matsuo67,68, Dimitrios Mavroudis91, Roger L Milne49,50,51, Taru A Muranen92, William G Newman41,42, Dong-Young Noh93, Børge G Nordestgaard18,19,20, Nadia Obi94, Andrew F Olshan95, Håkan Olsson9, Tjoung-Won Park-Simon36, Christos Petridis96, Paul D P Pharoah21,37, Dijana Plaseska-Karanfilska70, Nadege Presneau38, Muhammad U Rashid57,97, Gad Rennert98, Hedy S Rennert98, Valerie Rhenius37, Atocha Romero99, Emmanouil Saloustros100, Elinor J Sawyer101, Andreas Schneeweiss102,103, Lukas Schwentner73, Christopher Scott59, Mitul Shah37, Chen-Yang Shen104,105, Xiao-Ou Shu106, Melissa C Southey49,51,107, Daniel O Stram54, Rulla M Tamimi66,108, William Tapper39, Rob A E M Tollenaar109, Ian Tomlinson110,111, Diana Torres57,112, Melissa A Troester95, Thérèse Truong53, Celine M Vachon113, Qin Wang21, Sophia S Wang78,79, Justin A Williams26, Robert Winqvist114,115, Alicja Wolk55,116, Anna H Wu54, Keun-Young Yoo117,118, Jyh-Cherng Yu119, Wei Zheng106, Argyrios Ziogas7, Xiaohong R Yang6, A Heather Eliassen66,120, Michelle D Holmes66,120, Montserrat García-Closas6, Soo Hwang Teo89,121.   

Abstract

BACKGROUND: It is not known whether modifiable lifestyle factors that predict survival after invasive breast cancer differ by subtype.
METHODS: We analyzed data for 121,435 women diagnosed with breast cancer from 67 studies in the Breast Cancer Association Consortium with 16,890 deaths (8,554 breast cancer specific) over 10 years. Cox regression was used to estimate associations between risk factors and 10-year all-cause mortality and breast cancer-specific mortality overall, by estrogen receptor (ER) status, and by intrinsic-like subtype.
RESULTS: There was no evidence of heterogeneous associations between risk factors and mortality by subtype (P adj > 0.30). The strongest associations were between all-cause mortality and BMI ≥30 versus 18.5-25 kg/m2 [HR (95% confidence interval (CI), 1.19 (1.06-1.34)]; current versus never smoking [1.37 (1.27-1.47)], high versus low physical activity [0.43 (0.21-0.86)], age ≥30 years versus <20 years at first pregnancy [0.79 (0.72-0.86)]; >0-<5 years versus ≥10 years since last full-term birth [1.31 (1.11-1.55)]; ever versus never use of oral contraceptives [0.91 (0.87-0.96)]; ever versus never use of menopausal hormone therapy, including current estrogen-progestin therapy [0.61 (0.54-0.69)]. Similar associations with breast cancer mortality were weaker; for example, 1.11 (1.02-1.21) for current versus never smoking.
CONCLUSIONS: We confirm associations between modifiable lifestyle factors and 10-year all-cause mortality. There was no strong evidence that associations differed by ER status or intrinsic-like subtype. IMPACT: Given the large dataset and lack of evidence that associations between modifiable risk factors and 10-year mortality differed by subtype, these associations could be cautiously used in prognostication models to inform patient-centered care. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 33500318      PMCID: PMC8026532          DOI: 10.1158/1055-9965.EPI-20-0924

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  49 in total

1.  Choice of time scale and its effect on significance of predictors in longitudinal studies.

Authors:  Michael J Pencina; Martin G Larson; Ralph B D'Agostino
Journal:  Stat Med       Date:  2007-03-15       Impact factor: 2.373

2.  Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Authors:  Rowan T Chlebowski; JoAnn E Manson; Garnet L Anderson; Jane A Cauley; Aaron K Aragaki; Marcia L Stefanick; Dorothy S Lane; Karen C Johnson; Jean Wactawski-Wende; Chu Chen; Lihong Qi; Shagufta Yasmeen; Polly A Newcomb; Ross L Prentice
Journal:  J Natl Cancer Inst       Date:  2013-03-29       Impact factor: 13.506

3.  Survival of women with node negative breast cancer in the Auckland region.

Authors:  A E Lethaby; B H Mason; V J Harvey; I M Holdaway
Journal:  N Z Med J       Date:  1996-09-13

Review 4.  Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies.

Authors:  Xinnian Yu; Siying Zhou; Jinyan Wang; Qian Zhang; Junchen Hou; Lingping Zhu; Yunjie He; Jianhua Zhao; Shanliang Zhong
Journal:  Breast Cancer       Date:  2017-06-10       Impact factor: 4.239

5.  Reproductive history and mortality after breast cancer diagnosis.

Authors:  Maura K Whiteman; Susan D Hillis; Kathryn M Curtis; Jill A McDonald; Phyllis A Wingo; Polly A Marchbanks
Journal:  Obstet Gynecol       Date:  2004-07       Impact factor: 7.661

6.  Cancer recurrence and mortality in women using hormone replacement therapy: meta-analysis.

Authors:  Linda N Meurer; Sarah Lená
Journal:  J Fam Pract       Date:  2002-12       Impact factor: 0.493

7.  Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.

Authors:  André Hennigs; Fabian Riedel; Adam Gondos; Peter Sinn; Peter Schirmacher; Frederik Marmé; Dirk Jäger; Hans-Ulrich Kauczor; Anne Stieber; Katja Lindel; Jürgen Debus; Michael Golatta; Florian Schütz; Christof Sohn; Jörg Heil; Andreas Schneeweiss
Journal:  BMC Cancer       Date:  2016-09-15       Impact factor: 4.430

8.  The proportion of missing data should not be used to guide decisions on multiple imputation.

Authors:  Paul Madley-Dowd; Rachael Hughes; Kate Tilling; Jon Heron
Journal:  J Clin Epidemiol       Date:  2019-03-13       Impact factor: 6.437

9.  The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer.

Authors:  Chantal C Orgéas; Per Hall; Lena U Rosenberg; Kamila Czene
Journal:  Breast Cancer Res       Date:  2008-12-16       Impact factor: 6.466

10.  Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population.

Authors:  Mustapha Abubakar; Hyuna Sung; Devi Bcr; Jennifer Guida; Tieng Swee Tang; Ruth M Pfeiffer; Xiaohong R Yang
Journal:  Breast Cancer Res       Date:  2018-09-18       Impact factor: 6.466

View more
  2 in total

Review 1.  Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis.

Authors:  Yuanjie Pang; Yuxia Wei; Christiana Kartsonaki
Journal:  Breast Cancer       Date:  2022-05-17       Impact factor: 3.307

2.  Increased Prevalence of Breast and All-cause Cancer in Female Orthopaedic Surgeons.

Authors:  Loretta B Chou; Brianna Johnson; Lauren M Shapiro; Stephanie Pun; Lisa K Cannada; Antonia F Chen; Lindsey C Valone; Sara S Van Nortwick; Amy L Ladd; Andrea K Finlay
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.